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Background: Individuals in conflict-affected areas rarely get appropriate care for chronic or non-infectious
diseases. The prevalence of gestational diabetes mellitus (GDM) is increasing worldwide, and new evidence
shows conclusively that the negative effects of hyperglycemia occur even at mild glucose elevations and that
these negative effects can be attenuated by treatment. Scientific literature on gestational diabetes in refugee
camp settings is critically limited.
Methods: A 75 g 2-hour glucose tolerance test was administered to 228 women attending the antenatal care
(ANC) clinic in Maela refugee camp on the Thai Myanmar border. Prevalence of GDM was determined
using the HAPO trial cut-offs []92 mg/dL (fasting),]180 (1 hour), and]153 (2 hour)] and the WHO
criteria []126 mg/dL (fasting), and 140 mg/dL (2 hour)].
Results: From July 2011 to March 2012, the prevalence of GDM was 10.1% [95% confidence interval (CI):
6.2 14.0] when the cut-off determined by the HAPO trial was applied. Applying the older WHO criteria
yielded a prevalence of 6.6% (95% CI 3.3 9.8). Age, parity, and BMI emerged as characteristics that may be
significantly associated with GDM in this population. Other risk factors that are commonly used in screening
guidelines were not applicable in this diabetes-naı ¨ve population.
Discussion: The prevalence of GDM is lower in this population compared with other populations, but still
complicates 10% of pregnancies. New evidence regarding gestational diabetes raises new dilemmas for health-
care providers in resource-poor settings. Efforts to identify and treat patients at risk for adverse outcomes
need to be balanced with awareness of the risks and burdens associated with over diagnosis and unnecessary
interventions. Screeningapproaches based on risk factors or using highercut-off values may help minimize this
burden and identify those most likely to benefit from intervention.
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G
estational diabetes mellitus (GDM), defined as
glucose intolerancedevelopingor firstrecognized
during pregnancy, has been identified worldwide
as an increasingly common complication of pregnancies.
This is a new threat to the health of women in low- and
middle-income countries (1) and refugee populations,
where obesity and overweight are emerging (2). There
are very few published studies on GDM in the refugee
camp setting, although the need for services to manage
chronic diseases, including diabetes, in refugee settings has
been recognized (3).
Recent solid evidence for the negative impact of
GDM on pregnancy and the benefit of treatment comes
from the Hyperglycemia and Adverse Pregnancy Out-
comes (HAPO) study: a large multinational prospective
study that included 25,505 women in the third trimester
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(page number not for citation purpose)of pregnancy (4). The frequency of the primary outcomes
(primary cesarean delivery, clinical neonatal hypoglyce-
mia, and birth weight or cord serum C-peptide above
the 90th percentile) and secondary outcomes (premature
delivery,shoulderdystociaorbirthinjury,intensiveneonatal
care,hyperbilirubinemia,andpreeclampsia)increasedwith
increasing maternal glucose levels without a clear thresh-
old effect. Notably, these associations were detected even
for blood glucose levels that were previously considered
normal and did not differ among the 15 centers in nine
countries that participated in the study. Published a few
years earlier, the Australian Carbohydrate Intolerance
Study in Pregnant Women (ACHOIS) trial demonstrated
convincingly that treating mild gestational hyperglycemia
resulted in improved outcomes (5).
This has led to recommendations for adopting more
sensitive screening tests, but controversy remains. The
United States has adopted a universal screening policy,
whereas the UK, Australia and Thailand, among others,
screen based on risk factors (6). Screening programs in
developing countries are even more ad hoc and hetero-
geneous (7). The risk factors that areincluded in screening
guidelines may differ from country to country but often
include family history of diabetes, history of previous
macrosomic baby, obesity, high-risk ethnicity, GDM in
previous pregnancy, and advancing age.
In 1999, the WHO recommended thresholds for a
2hour75gglucosetolerancetestof ]126mg/dL(fasting)
and 140 mg/dL (2 hour), with a screening test considered
positive if a single value is elevated (8). The HAPO study
(4) and the International Association of Diabetes Preg-
nancy Study Group (IADPSG) (5) proposed the thresh-
oldsof ]92(fasting),180(1hour),and153mg/dL(2hours)
(4, 9). Still other, less widely recognized, cut-offs have
been proposed in the literature (9 11). An often-cited
review byRyanet al. (11) suggested screening cut-offs that
would give a twofold increased risk of fetal macrosomia
(fasting ]95 mg/dL, 1 hour]191 mg/dL, and 2 hour
]162 mg/dL). Until very recently, the United States
continued to use a two-step screen with a 50 g and 100 g
glucose challenge, further confounding efforts to make
international comparisons (6, 7).
Critics have questioned the benefit of increasingly
sensitive GDM screening tests that may promote inter-
ventions, with their inherent risks, even in mild cases
where intervention will cause only a marginal reduction
in adverse outcomes (7, 9, 11 13). In addition, strategies
developed to date for GDM screening and testing have
not taken into account feasibility and applicability for
resource-poor settings (7).
Starting in 2011, the Shoklo Malaria Research Unit
(SMRU) clinic in Maela refugee camp began a pilot
diabetes screening program to try to address the increas-
ing prevalence of overweight in our antenatal care (ANC)
population. The percent of ANC patients with high-risk
body mass index (BMI), defined as BMI ]27.5 kg/m
2,h a s
increased from 4.2% in 2003 2005 to 7.9% in 2009 2012.
This increase in overweight has been a consistent trend
despite ongoing rates of underweight (BMI B18.5 kg/m
2)
around 10% in the same population.
Recently published research in the neighboring Thai
KarenvillagesinThasongyang,Thailand,showeda16.72%
prevalence of impaired fasting glucose (]100 mg/dL).
This was significantly higher in women compared with
men (21.02 vs. 10.57, pB0.05) (14). The same group also
demonstrated that overall knowledge about diabetes is
very low in this population, and is significantly lower
among women than men (15). Only 27.1% of survey res-
pondentsofeithergenderknewthatpregnantwomenwere
at risk for diabetes.
The objective of this analysis is to estimate the propor-
tion of pregnant women in a refugee camp affected by
GDM based on the first results of this pilot screening
program. Secondary objectives included analysis of base-
line characteristics associated with GDM and outcomes.
Our hypothesis was that the prevalence of GDM in
this refugee population would be lower than in other
Asian populations, but that associated characteristics
and outcomes associated with GDM would be similar.
This hypothesis was based on the fact that underweight
and undernutrition remain significant health issues in
the refugee population (16). This coexistence of obesity
and undernutrition in a single population, known as the
nutritional transition, has been described throughout the
developing world (17).
The results will help inform guidelines for diabetes
screening in this and neighboring pregnant populations.
Methods
Setting
About 140,000 refugees from Myanmar have been housed
in refugee camps along the Thai Myanmar border since
the1980s(18).TheShokloMalariaResearchUnit(SMRU)
provides the antenatal and delivery care for the popu-
lation of the Maela refugee camp, the largest of nine
refugee camps in western Thailand. Approximately 90%
of pregnant women in the refugee camp receive ANC at
the SMRU clinic (19). The patient population consists
of 45 50,000 people of multiple ethnic groups, predomi-
nantly Karen, who have been displaced from their homes
inMyanmar.A limitednumberofjobsareavailablewithin
the camp in various social services (health, education,
child protection, etc.) and remittances are sent back to
the camp from relatives working in Thailand or abroad.
Rations of rice, dried fish, and chili are provided, with
additional rations of a fortified flour mix, oil and
dried peas for children under five, older children who
are malnourished, and pregnant women. These rations
are being gradually decreased due to funding cuts, and
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informalmarketswithinthecampareexpandingandsome
vegetables, meat and various prepared foods are available
for purchase, sold by camp residents. Some families have
small kitchen gardens at their houses, but space is limited.
Camp residents are forbidden from traveling outside the
camp without pre-arranged permission with camp autho-
rities. As a result, farming and foraging for locally known
wild vegetables, two activities that would traditionally
provide exercise and improved nutrition for women, are
limited.
Individuals living outside the camp in villages in
Myanmar or Thailand who share the same languages
also access SMRU’s delivery room. The clinic has a
delivery room that provides delivery services for about
1,500 women per year but does not have insulin or the
capability to perform cesarean section on site. Patients
requiring cesarean delivery are transported for about
an hour to the closest emergency obstetric services in
Thailand at Mae Sot Hospital. SMRU also provides a
similar service for migrant women in two settings outside
the refugee camp.
General medical care in the camp is provided by
Premie `re Urgence   Aide Me ´dicale Internationale and
there is currently no published data on the prevalence of
diabetes in the general camp population.
From 5 July 2011 to 6 March 2012, women receiving
ANC in the SMRU clinic in Maela camp were invited to
come for diabetes screening at between 24 and 28 weeks
of gestation. Due to staff time constraints, a maximum of
two patients were recruited per day for this pilot program.
The staff was instructed to invite consecutive patients
based on staff availability and not on patient character-
istics. Unfortunately, the total number of patients invited
to come was not recorded, andwe cannot quantify the res-
ponse rate. Capillary blood glucose levels were measured
when fasting, and then 1 and 2 hours after ingestion of
75 g of anhydrous glucose dissolved in 200 ml of water.
Capillary sampling has been shown to be a cost-effective
alternative to venous sampling in low-resource settings
(20).
Sample size calculation
A sample size of 216 was the minimum needed to
estimate the prevalence of GDM in this population,
assuming a prevalence of around 10% with a confidence
interval of 94%. Analysis was performed on the first 228
completed tests. This included an additional 12 patients
( 5%) to account for the possibility of drop-out from
ANC before pregnancy outcome was known.
Data extraction
All birth records from July 5, 2011, to March 6, 2012, were
audited and the data were extracted and anonymized for
analysis.
Ethical approval
Ethical approvalwas given by the Oxford Tropical Research
Ethics Committee for the use of the antenatal records
(OXTREC 28-09).
Statistical analysis
Data were analyzed using Stata version 12.0 (StataCorp,
College Station, TX, USA). Continuous normally distri-
buted data were described using the mean and standard
deviation, and non-normally distributed data using the
median and range. Categorical data were summarized
using frequency and percent. Means were compared with
the Student’s t-test, medians with Mann Whitney U test
and proportions with the Chi-squared test. Logistic re-
gression was used to evaluate the interactions between
variables, but this was limited by the small sample size.
Results
The first 228 patients with completed screening test
results available were included in the analysis.
Prevalence of GDM
Analysis of the 228 oral glucose tolerance test results
using the HAPO criteria (4) yielded a GDM prevalence
of 10.1% (23/228) (95% CI 6.1 14.0); 6.6% (15/228)
(95% CI 3.3 9.8) using the older WHO criteria (7) and
5.3% (12/228) (95% CI 2.3 8.2) with criteria proposed by
Ryan et al. (11). Ryan’s criteria identified about half of
those who would be identified using the stricter HAPO
criteria (12 of the 23). The WHO criteria, on the contrary,
concurred less well with the HAPO results. WHO criteria
identified five individuals as having GDM who were not
identified using HAPO criteria and failed to identify 13
women who were identified by HAPO.
Patient characteristics associated with GDM
Information on baseline characteristics was available for
all 228 women tested. There was a significantly greater
mean age and higher proportion of illiteracy in the GDM
group (Table 1) although illiteracy was not statistically
significant after controlling for age (p 0.114). Higher
parity approached significance (p 0.05).
Other variables such as ethnicity (multiple ethnic
groups from Myanmar are represented in the camp),
blood pressure, fundal height, history of stillbirth, and
country (Thailand or Myanmar) of birth were found not
to be associated with GDM in this cohort. Likewise
historical criteria (e.g. family history of diabetes, personal
history of pre-diabetes) used in some countries to select
pregnant women for screening due to increased risk asso-
ciatedwiththesefactors,werenotassociatedwithGDMin
this setting. There was no statistically significant increase
in BMI or history of previous cesarean section. The small
number of GDM in this study precluded a formal risk
factor analysis.
GDM prevalence in Maela refugee camp
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In the cohort of 228 pregnant women, delivery out-
comes were known for 221 patients, including all patients
who screened positive for GDM. Seven women were lost
to follow-up before delivery and those without known
outcomes were excluded from the subsequent analysis.
These 221 outcomes included normal vaginal delivery
90.5% (200/221): at SMRU (180) or at a Thai Hospital (7)
or at home (13); vaginal breech delivery at SMRU 1.8%
(4), vacuum delivery at SMRU 1.4% (3), and cesarean
section delivery at the Thai Hospital 6.3% (14).
Of the 212 newborns with birth weight measured in the
first 24 hours, the mean birth weight for the GDM group
was 3,175 g (range 2,050 3,900) compared with 3,036 g
(range 1,500 4,230) in the screen normal group (p 0.11).
Of the five infants born weighing 4 kg or more in this
cohort, none were born to women who screened positive
for GDM. There were no neonatal deaths. Two intrapar-
tum fetal deaths occurred in non-diabetic pregnancies,
one following placental abruption and the second with a
complicated delivery of a second twin.
The proportion of cesarean delivery (as the outcome
for the current pregnancy) was 13.0% (3/23) in diabetic
patients and 6.1% (12/198) in non-diabetic patients,
(p 0.360). There was no significant difference in esti-
mated gestational age at delivery (39.3 weeks for GDM
group vs. 39.0 weeks non-diabetic group, p 0.24) or
APGAR scores at 1 and 5 min (median 9, 10 for both
groups).Sixinfants,allinthenon-diabeticgroup,required
resuscitation and resuscitation data were not available for
one diabetic woman, who underwent cesarean delivery at
the Thai hospital.
Conclusions
This is the first report of GDM prevalence in a refugee
camp using HAPO criteria. Refugee healthcare is often
basedonemergencyresponsesandchronic,non-infectious
diseases such as diabetes are often poorly addressed due
to lack of perceived urgency as well as cost and very real
logistical difficulties in providing long-term continuity
of care. The low prevalence of 10% is not surprising in a
refugee population where nutrition remains an issue (16)
and micronutrient deficiency of thiamine was the most
common cause of infant deaths just two decades ago (21).
However, a recent review of GDM prevalence worldwide
showed Southeast Asian populations to have the highest
prevalence overall, with an average 23% (HAPO criteria)
of pregnancies affected (22). Management of gestational
diabetes involved exogenous insulin in only 8 20% of
women in two recent large multi-center treatment studies
[the Maternal-Fetal Medicine Units (MFMU) study (23)
(23) and the ACHOIS study (5)] so the great majority of
women with gestational diabetes have improved outcomes
with diet, lifestyle modification, oral hypoglycemic drugs
and glucose monitoring alone. A study of GDM in the
United Nations Relief and Works Agency (UNRWA)
clinics of Gaza showed significant improvement of out-
comeswith an educational intervention (24). These nonin-
vasive treatments are potentially available in low-resource
settings and could reduce the risk of cephalo-pelvic
disproportion and shoulder dystocia, and need for cesar-
ean section.
On the other hand, implementing a universal screening
strategy in this setting comes with some inherent costs.
The staff time required to administer a 2 hour test to 1,500
women per year (the average case load in the Maela ANC
clinic) is significant, and like most resource-poor settings,
will further burden a limited staff. In addition, it has been
suggested that the HAPO criteria may yield more false-
positive tests in a real world setting than they did in the
carefully regimented study setting due to surreptitious or
accidental non-fasting status (13). This might be espe-
cially true in our setting where literacy and health literacy
are quite low. This low literacy means that effective cou-
nseling on diet and exercise will be more time intensive, as
patient handouts are of limited use. Increasing the rate of
cesarean deliveries by inappropriately assigning high-risk
status to low-risk patients can lead to serious risks in
subsequent pregnancies, especially in a mobile population
that frequently lack access to appropriate emergency or
operative obstetric services.
Taking all of these factors into account, we tentatively
suggest that a risk-factor-based screening might identify
Table 1. Characteristics of women according to screening results following the 75 g oral glucose tolerance test
Risk factor characteristic Positive*, N 23 Negative, N 205 p
Age, years 29 (6.3) [16 43] 26 (6.5) [15 46] 0.039
Parity (median) 2 [0 5] 1 [0 9] 0.050
BMI at 22 weeks gestation, mg/kg
2 (median) 24.2 [20 32.4] 23.2 [16 39.6] 0.454
Proportion overweight (BMI]27.5 kg/m
2) 4/23 (17.4%) 16/205 (7.8%) 0.123
Literacy, n (%) 12/23 (52.2) 151/205 (73.7) 0.030
Previous cesarean section, n (%) 2/23 (8.7) 8/204 (3.9) 0.290
Data are reported as mean (SD) [range] unless otherwise stated.
*HAPO criteria used.
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unnecessarily burdening staff and patients with unneces-
sary testing.
This analysis is limited by several factors. Since this
screening was conducted in a clinical setting without
supervision of the women the night before the test, fasting
status of the patients involved could not be guaranteed.
As the exact percentage of patients who were invited for
screening was not recorded, we cannot exclude the pos-
sibility of selection bias. However, the very low level of
local awareness of GDM (15) makes staff selection or self-
selection of high-risk patients unlikely. Finally, the small
sample size limits the strength of outcome analysis and
precludes formal risk factor analysis.
Despite these limitations, analysis of this cohort sheds
some light on characteristics that could be used to identify
patients in this population at higher risk for an abnormal
screening test result, potentially conserving resources and
reducing the numberof false-positive results. As expected,
it appears that high parityand maternal age areassociated
with GDM in this population. Though we did not show
a statistically higher BMI in the GDM group, long-term
outcomes of infants of mothers with GDM and obesity
are worse than infants of mothers with GDM and normal
BMI (8). For this reason, it would be logical to include
obese women in screening algorithms.
The lack of association with features of history, family
history of GDM and personal history of glucose intol-
erance, is expected in a setting where chronic under
diagnosis and under treatment of diseases like diabetes
are combined with low health literacy. This was likewise
reported in a recent review on the practicalities of
GDM screening in resource-poor settings (7). However,
thesehistorical risk factors may become moreuseful inthe
future if screening and educational programs increase
local awareness of diabetes. In the UNRWA clinics in
Gaza Strip, where non-communicable diseases are the
primary health focus, prior macrosomia or family history
of diabetes was strongly correlated with GDM (25). In
addition, prior history of abortion or of stillbirth was a
significant risk factor in their population. In our popula-
tion, these were no different in the two groups, possibly
because of a higher rate of infectious causes of stillbirth
and abortion. Prior history of cesarean delivery was also
a significant risk factor in the UNRWA clinics. In our
population, the women with GDM were twice as likely to
have a previous history of cesarean delivery, but in our
smallsamplethiswasnotsignificant(Table1).Ahistoryof
previous cesarean section may be a surrogate marker for
previous undiagnosed GDM, and these patients should be
screened.
Diabetes has generally been considered a disease of
abundance, but this report shows it complicates one in
10 20 pregnancies in this refugee situation, depending on
the diagnostic criteria applied. In 2010, the UNHCR (26)
estimated that 15.4 million individuals have been forced
to cross international borders to become refugees, and to
our knowledge GDM screening has been described in
only one other refugee camp setting (Gaza Strip) (24, 25).
Despite the weight of evidence for the benefits of early
diagnosis and treatment of GDM, the absence of a simple,
inexpensive and applicable screening method remains
a major barrier to GDM screening programs in refugee
camps and other resource-poor settings.
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